FDA Drug Recalls

Recalls / Class II

Class IID-0167-2021

Product

Sildenafil Tablets USP 100 mg, Rx Only, 100-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-748-01.

Affected lot / code info
Lot: 36884 Exp. 03/2022

Why it was recalled

Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.

Recalling firm

Firm
AVKARE Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
615 N 1st St, N/A, Pulaski, Tennessee 38478-2403

Distribution

Quantity
38715 bottles
Distribution pattern
Nationwide within the U.S.

Timeline

Recall initiated
2020-12-07
FDA classified
2020-12-16
Posted by FDA
2020-12-23
Terminated
2023-10-16
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0167-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls